IWGGD Collaboration

Working together to improve Gaucher care

The International Gaucher Alliance works closely with the International Working Group on Gaucher Disease (IWGGD) to bring patient perspectives into research, clinical guidance and discussions about the future of Gaucher disease care.

The IWGGD is an independent, non-profit network that brings together clinicians, researchers and patients to promote clinical and basic research in Gaucher disease, with the ultimate aim of improving patients’ lives.

Putting patients at the heart of collaboration

The IGA contributes the perspectives and experiences of people living with Gaucher disease to IWGGD activities.

In 2025, IGA representatives participated in IWGGD working groups covering:

Epilepsy in Gaucher disease type 3

Ambroxol

Home therapy

Self-management

Transition

Coordination of care

This work helps bring patient experience into discussions about research and clinical care.

From collaboration to practical change

The IGA and IWGGD have worked together on projects that aim to address issues identified by the Gaucher community.

Home therapy

The IGA and IWGGD collaborated on work exploring home enzyme replacement therapy and developing recommendations around home treatment. A resulting review was published in the Journal of Clinical Medicine in 2025.

Self-management

IGA representatives have contributed to the development of self-management guidance, recognising the importance of supporting people to manage the everyday impact of Gaucher disease alongside clinical care.

Transition and coordination of care

The collaboration has also contributed to guidance addressing transition from paediatric to adult care and coordination of care.

The IWGGD Symposium

The IWGGD holds a symposium every two years, providing a forum for clinicians, researchers and patients to share knowledge and discuss developments in Gaucher disease.

The 3rd IWGGD Symposium took place in Trieste, Italy, from 3–6 May 2026, under the theme “Bridging the Gap: From Basic Research to Patient Care”. The programme included scientific sessions, working groups and dedicated patient-perspective sessions.

The IGA was actively involved in the 2026 programme, including a session focusing on the situation in Africa and ongoing IGA initiatives.

A shared commitment

The strength of the IGA–IWGGD relationship comes from bringing different perspectives together:

Patients and caregivers

Lived experience and priorities

Clinicians and researchers

Clinical knowledge and scientific expertise

Together

Better-informed research, guidance and care

About the IWGGD

The International Working Group on Gaucher Disease is an independent, non-profit network established to promote clinical and basic research into Gaucher disease. It brings together clinicians, scientists and patients in an open forum covering different aspects of Gaucher disease.